Rothschild Investment LLC’s Ligand Pharmaceuticals LGND Stock Holding History

Rothschild Investment LLC’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$86.6K	Buy	434 +1	+0.2%	+$198	﹤0.01%	944
2025 Q4	$81.9K	Hold	433	–	–	﹤0.01%	869
2025 Q3	$76.7K	Buy	433 +2	+0.5%	+$297	﹤0.01%	874
2025 Q2	$49K	Hold	431	–	–	﹤0.01%	788
2025 Q1	$45.3K	Buy	431 +10	+2%	+$1.13K	﹤0.01%	795
2024 Q4	$45.1K	Hold	421	–	–	﹤0.01%	802
2024 Q3	$42.1K	Buy	421 +15	+4%	+$1.51K	﹤0.01%	823
2024 Q2	$34.2K	Sell	406 -200	-33%	-$15.9K	﹤0.01%	845
2024 Q1	$44.3K	Hold	606	–	–	﹤0.01%	752
2023 Q4	$43.3K	Buy	+606	New	+$35.8K	﹤0.01%	681

Other funds holding LGND

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

Rothschild Investment LLC's LGND Position: Q1 2026 in Review

Rothschild Investment LLC increased its Ligand Pharmaceuticals (LGND) stake by 0.23% in Q1 2026, buying an estimated $198 and bringing the position to 434 shares worth $86.6K. The position accounts for ﹤0.01% of the portfolio, ranked #944.

Rothschild Investment LLC first reported a position in LGND in Q4 2023 and has held it in 10 quarters since. 357 funds tracked by Wall St. Rank hold LGND as of Q1 2026.

Rothschild Investment LLC held 434 shares of Ligand Pharmaceuticals worth $86.6K as of Q1 2026.
Rothschild Investment LLC bought 1 Ligand Pharmaceuticals share in Q1 2026, an estimated $198.
Ligand Pharmaceuticals made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q1 2026, its #944 holding.
Rothschild Investment LLC first reported a position in Ligand Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
357 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.

Based on Rothschild Investment LLC's 13F filing for Q1 2026, filed 7 May 2026.